Summary: "Recombinant Anti-B cell lymphoma 38C13 Idiotype x Anti-CD44 Bispecific Antibody (TandAb) is designed to be expressed as a monomeric subunit (single chain Diabody, scDb), with four variable domains from two parental antibodies. Then the two peptide chains can dimerize in a head-to-tail fashion. This BsAb can block cell adhesion. It is designed for the research of B cell lymphoma therapy. https://www.creative-biolabs.com/bsab/symbolsearch-b%2520cell%2520lymphoma%252038c13%2520idiotype%2520%2526%2520cd44.htm"